Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.

Using a circuit-based system, scientists determined the ideal transcription factor levels to promote the successful reprogramming of fibroblasts into induced pluripotent stem cells.

A snapshot of the most highly ranked articles in developmental biology, from Faculty of 1000

Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.

Through cellular reprogramming, researchers have produced a novel pluripotent mouse stem cell in vitro.

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

By comparing stem cells from six mammals of different sizes, scientists discovered stark differences in embryonic development paces.

Removing a specific miRNA from stem cells may induce the expression of endogenous retroviruses that enable the cells to form extra-embryonic lineages.

Stem cells and cancer cells have enough molecular similarities that the former can be used to trigger immunity against the latter.